Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air
| Status: | Recruiting |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Start Date: | May 2013 |
| Contact: | Jamie Ketas |
| Email: | Jamie.Ketas@ehmc.com |
| Phone: | 201-894-3418 |
Volatile Organic Compounds (VOC) in human breath are captured and analyzed by the
Spectrosense EVA system, which is combination of a gas chromatography (GC) and software
algorithm. The objective is to obtain a set or sets of VOC bio-markers that will provide the
best discrimination between Breast Cancer sick population and healthy population. The gold
standard for identifying sick/healthy population is biopsy proven breast cancer.
Spectrosense EVA system, which is combination of a gas chromatography (GC) and software
algorithm. The objective is to obtain a set or sets of VOC bio-markers that will provide the
best discrimination between Breast Cancer sick population and healthy population. The gold
standard for identifying sick/healthy population is biopsy proven breast cancer.
Breast Cancer group:
Inclusion Criteria:
- Age from 18 years old
- Breast cancer positive biopsy
- Before any treatment
- Signed Informed Patient Consent
Exclusion Criteria:
- Age under 18 years old
- Neoadjovant treatment
- Post surgery for breast cancer
- A history of any other cancer type, except skin cancer that is not melanoma
Healthy group:
Inclusion Criteria:
- Healthy women
- No history of Breast cancer
- Signed Informed Patient Consent
Exclusion Criteria:
- History of Breast cancer
- Breast cancer background in the family
- A history of any other cancer type, except skin cancer that is not melanoma
We found this trial at
1
site
Englewood Hospital and Medical Center Englewood Hospital was incorporated in 1888 as a non-profit, non-sectarian...
Click here to add this to my saved trials
